AI assistant
Sending…
vTv Therapeutics Inc. — Director's Dealing 2021
May 5, 2021
34596_dirs_2021-05-05_b5eea4ae-c3ea-4a5b-a05e-1b2856fdef6b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: vTv Therapeutics Inc. (VTVT)
CIK: 0001641489
Period of Report: 2021-05-03
Reporting Person: Weiner Howard L. (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-05-03 | Director stock option (right to buy) | $2.54 | A | 15000.00 | Acquired | 2031-05-03 | Class A Common Stock (15000.00) | Direct |
Footnotes
F1: The option vests in monthly installments over the three year period beginning May 3, 2021.
More from vTv Therapeutics Inc.
Share Issue/Capital Change
2026
May 13
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 13
Investor Presentation
2026
Feb 26
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18
Regulatory Filings
2026
Feb 2
Board/Management Information
2025
Dec 19
Major Shareholding Notification
2025
Dec 9